Canna Law Blog

SEPTEMBER 9, 2020

The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule. DEA Laboratory Registration. This topic goes to the requirement that all hemp be tested for “total THC.” Cannabis plants with total THC levels higher than.3%,

Hemp 67

Hemp CBD DEA Topical 67

Canna Law Blog

DECEMBER 4, 2019

The hemp industry is up in arms over the USDA’s interim rules establishing a domestic hemp program. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC. 3% Total THC.

Hemp 69

Hemp DEA CBD THC 69

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. Drug Enforcement Agency (DEA). We could potentially develop north of 11,000 drugs that are cannabinoid-based. territories. Is the future exciting? Absolutely.” The post New U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 28, 2022

An Examination of the USDA Hemp Production Program. Hemp Roundtable Vice President and CEO of Kentucky-based Ecofibre, Eric Wang, testified alongside Kentucky Commissioner of Agriculture, Ryan Quarles, during a Congressional hearing regarding “ An Examination of the USDA’s Hemp Production Program.” Washington D.C.

Agriculture 52

Agriculture Hemp CBD Research and Development 52

Cannabis Law Report

AUGUST 18, 2022

One year after the United States Department of Agriculture (USDA) issued its final rules on hemp, various states enacted their own regulatory programs. An ISO 17025-compliant, DEA-licensed, and CLIA-licensed laboratory, ACS Laboratory offers the largest state-of-the-art testing facility in cannabis and hemp testing in the eastern U.S.

Compliance 52

Compliance Compliance Hemp Research and Development 52

Veriheal

DECEMBER 28, 2021

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S.

Research and Development 93

Research and Development Chronic Pain Treatment Medicine 93

United Patients Group

APRIL 3, 2023

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. Another for of ‘prescribed’ cannabis is Marinol , which is synthetic THC, developed in the 80’s and used for such conditions as Cancer and AIDS. Cannabis is a schedule 1 substance.

DEA 52

DEA Patients Conditions Cannabis 52

Cannabis Law Report

JUNE 4, 2021

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. Although, more like beer and wine as compared to hard liquor in the alcohol industry, we realize the immense popularity of Delta-8.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Canna Law Blog

AUGUST 30, 2020

However, this (1) did not offer any help for hemp cultivated in states with hemp programs that were inconsistent with the 2014 Farm Bill, and (2) is only guidance and was not legally binding on any court or law enforcement agency. During transport, the hemp is exposed to too much heat, and the delta-9 THC levels increase.

Hemp 98

Hemp Agriculture Extraction THC 98

Canna Law Blog

JANUARY 17, 2020

HR 5587, as currently drafted, only would apply to Hemp CBD, not other cannabinoids such as CBN or CBG. The 2018 Farm Bill encompasses all hemp-derived cannabinoids in its definition of “hemp” so HR 5587 could encompass more than just CBD without having to amend the Farm Bill.

Hemp 97

Hemp CBD Food Cannabinoids 97

MedicalJane

JUNE 29, 2018

Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JULY 30, 2021

It also includes comprehensive restorative justice provisions, including grants, loans, and other funding programs for disadvantaged and minority businesses, record expungement, petitions for resentencing, and other measures intended to repair the decades of harm caused by the War on Drugs. Delta-9 THC. Cannabis above 0.3%

Hemp 105

Hemp Law Seed-To-Sale Food 105

Veriheal

AUGUST 31, 2020

Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.

Media 52

Media CBD Events THC 52

Canna Law Blog

FEBRUARY 2, 2020

The North Carolina Department of Agriculture (“NCDA”) provides a useful summary of the state’s law regarding hemp cultivation: Hemp production has been legalized in North Carolina, but only as part of the state’s pilot program as allowed under federal law. THC will result in a negligent violation. .”

Hemp 102

Hemp CBD Agriculture Cultivation 102

Cannabis Law Report

JANUARY 13, 2022

1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. 1, out-of-state medical marijuana patients may access Arkansas’ program to purchase cannabis for up to 90 days. Kansas Attorney General Calls Delta-8 THC a Schedule I Controlled Substance. Louisiana: As of Jan.

Dispensary 52

Dispensary Law Concentrates DEA 52

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. 5 The so-called “hemp” market is no longer predominantly a wellness market.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

WeedAdvisor

SEPTEMBER 16, 2019

In just the past few weeks, this cannabinoid became the backbone of booming medical cannabis industries, especially in South America and some select parts of Europe. But we’re also painfully aware of the recent vaping crisis which, until now, focused on shady THC vapes, while nicotine e-liquids were caught in the crossfire.

CBD 45

CBD Vaping DEA Oil 45

The Cannigma

SEPTEMBER 12, 2021

There are a lot of different molecules in nature, and though cannabinoids are rather rare, they are extremely abundant in cannabis (hence the name). THC is the most prevalent, famous and researched cannabinoid by far. What is THC? THC is short for tetrahydrocannabinol. Who discovered THC? THC vs CBD.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

CannaMD

SEPTEMBER 15, 2020

Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients. .’ Who is eligible for medical marijuana?

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S.

Data 95

Data Vaping Supply Chain Business 95

The Cannigma

FEBRUARY 16, 2022

Well, these cannabis plants are making these trichomes, they’re fortifying and you’re telling me that the hot stuff is made in this cannabis trichomes, the cannabinoids and the terpenes, or many of the terpenes anyway? So, this is hot news right now, cannabinoid acids. CP: Like the THC for example.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Veriheal

AUGUST 19, 2022

looking to pursue cannabinoid research. The cannabis research material provided to researchers, such as Dr. Sue Sisley from the University of Mississippi, averages only 7% THC. In legal, regulated markets across the country, the average THC content in dried cannabis flower range anywhere from 10% to 30%.

Hemp 52

Hemp DEA Access Cultivation 52

Canna Law Blog

NOVEMBER 12, 2020

On October 27, the New York Department of Health (the “ DOH ”) released much anticipated proposed rules to regulate the processing, manufacturing, sale and marketing of cannabinoid hemp products in the state (the “ Rules ”). Broad spectrum means “a concentrate extracted from hemp containing multiple cannabinoids, but where all ?

Hemp 52

Hemp Extraction Cannabinoids Concentrates 52

SpeedWeed

FEBRUARY 24, 2021

3% THC , producers received an increase in the negligent threshold. 3% THC but less than 1% won’t be labeled as negligent, though remediation or disposal is still required. . Noncompliant hemp used to require its disposal or remediation be conducted by a government official from an agency like the DEA.

Hemp 52

Hemp DEA Research and Development Compliance 52

Cannabis Law Report

AUGUST 6, 2021

including building inventory and activating new production capacity along with higher third-party shipping, distribution and warehousing costs, partially offset by payroll subsidies received from the Canadian government in Q1 2022, pursuant to a COVID-19 relief program. In Edibles, the Company’s Twd.

Vaping 105

Vaping Research and Development Data Business 105

SpeedWeed

DECEMBER 28, 2018

Marinol (synthetic THC) has been available by prescription since 1986, and other synthetic cannabinoid drugs are in the works, but Epidiolex is the first plant-derived pharmaceutical to reach the US market. Buzz: Cannabis Equity Programs Expand Opportunities. The shop’s proprietor, Alphonso T Blunt, Jr.,

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program. The only problem is, the program doesn’t actually exist.

DEA 232

DEA Research and Development Clinical Trials Patients 232

Cannabis Law Report

JUNE 27, 2022

Greetings Friends: Welcome to my first installment industry news, “industry” meaning Cannabis, divided into marijuana and cannabinoids, and Psychedelics. Cannabinoids. OR bans synthetic cannabinoid products: [link]. million in the first month following launch of the program. [link]. cannabis-spring2022newsletter.

Seed-To-Sale 52

Seed-To-Sale Hemp Retail Treatment 52